Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8530953 | International Immunopharmacology | 2018 | 8 Pages |
Abstract
We have shown that rMal f 1 has ideal IgE binding ability and good correlation with binding activity to M. furfur. Moreover, we have revealed a hitherto unknown DC activation profile after rMal f 1 stimulation whereby TNF-α, IL-6, and IL-10 were significantly increased and IL-12 was unaltered, suggesting that rMal f 1 can predispose a DC bias toward the TH22/TH17 pathway beyond the routine IgE-dependent TH2 pathway, thus providing intriguing clues for clinical treatment involving both pathways.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Linmei Li, Shan Wang, Zehong Zou, Ailin Tao, Yuncan Ai,